Lv21
200 积分 2024-12-03 加入
Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial
25分钟前
待确认
Fibroblast Growth Factor Receptor Alteration Testing for >3600 Patients with Locally Advanced/Metastatic Urothelial Cancer and Non–muscle-invasive Bladder Cancer: An Analysis of the Global ANNAR Biomarker Study
9天前
已关闭
Facts and Hopes on the Use of Artificial Intelligence for Predictive Immunotherapy Biomarkers in Cancer
14天前
已完结
Translational PK–PD for targeted protein degradation
15天前
已完结
Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer
21天前
已完结
Targeted protein degradation in pancreatic cancer: advances and challenges of PROTAC-based therapeutics
21天前
已完结
Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial
22天前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
1个月前
已完结
Risk variant regulates pDC hyperactivation in SLE
1个月前
已完结
The essential roles of memory B cells in the pathogenesis of systemic lupus erythematosus
1个月前
已完结
皖公网安备34019202002308
